A quality study to improve prophylactic antithrombotic therapy prescribed to patients with atrial fibrillation

A quality study to improve prophylactic antithrombotic therapy prescribed to patients with atrial fibrillation

Introduction: Atrial fibrillation is the most common cardiac arrhythmia and has important clinical repercussions, increasing thromboembolic events and mortality. The CHA2DS2‐VASc and HAS‐BLED scores assist the clinician in assessing the benefits and risks of antithrombotic therapy. Objective: The ai...

Full description

Bibliographic Details
Main Authors: Rui Oliveira, Sandra Grilo, Carla Moreira, Jorge Santos, Rodolfo Feitor, Raquel Moreira, Martina Rocha
Format: Article
Language:English
Published: Elsevier 2014-02-01
Series:Revista Portuguesa de Cardiologia (English Edition)
Online Access:http://www.sciencedirect.com/science/article/pii/S2174204914000348

Internet

http://www.sciencedirect.com/science/article/pii/S2174204914000348

Similar Items